Canada markets closed

Biofrontera AG (B8F.HM)

Hamburg - Hamburg Delayed Price. Currency in EUR
Add to watchlist
6.30+6.00 (+2,000.00%)
At close: 08:46AM CEST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Total Revenue
30,163
32,249
25,738
28,787
30,346
-
Cost of Revenue
6,220
6,243
4,757
3,913
3,536
-
Gross Profit
23,942
26,005
20,981
24,873
26,810
-
Operating Expenses
Research Development
7,755
7,846
7,128
7,009
4,789
-
Selling General and Administrative
12,167
13,378
12,262
53,204
29,632
-
Total Operating Expenses
19,922
21,224
19,390
60,213
34,421
-
Operating Income or Loss
4,020
4,781
1,591
-35,340
-7,611
-
Interest Expense
14
15
163
3,720
3,080
-
Total Other Income/Expenses Net
-
-
-
-
-2,419
21,184
Income Before Tax
-1,439
-2,127
-43,210
35,683
-12,697
-
Income Tax Expense
-1,837
-1,758
956
2,397
326
-
Income from Continuing Operations
398
-369
-44,166
33,286
-13,023
-
Net Income
398
-369
-44,166
37,747
-13,023
-
Net Income available to common shareholders
398
-369
-44,166
37,747
-13,023
-
Basic EPS
-0.10
-0.21
-16.17
13.66
-4.82
-
Diluted EPS
-0.10
-0.21
-16.17
13.46
-4.82
-
Basic Average Shares
64,813
3,038
2,737
2,757
2,697
-
Diluted Average Shares
64,813
3,038
2,737
2,823
2,697
-